Transepithelial transport of fusariotoxin nivalenol: Mediation of secretion by ABC transporters

Toxicology Letters

Volumn 170, Issue 3, 2007, Pages 248-258

  Tep, Jonathan ^a   Videmann, Bernadette ^a   Mazallon, Michèle ^a   Balleydier, Sabine ^b   Cavret, Séverine ^a   Lecoeur, Sylvaine ^a  

^a CEMAGREF   (France)

^b VETAGRO SUP   (France)

Author keywords

Epithelial cells; Intestinal transfer; Multidrug resistance associated protein 2; Nivalenol; P glycoprotein; Trichothecene

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; GLYCOPROTEIN P INHIBITOR; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; MYCOTOXIN; NIVALENOL; T 2 TOXIN; VALSPODAR; VERLUKAST;

APICAL MEMBRANE; ARTICLE; BASAL CELL; CELL MEMBRANE TRANSPORT; CELL STRAIN CACO 2; CELL TRANSFER; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE DEPENDENCE; TOXICOKINETICS; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CELL LINE; CHROMATOGRAPHY, GAS; ELECTROCHEMISTRY; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYCOTOXINS; P-GLYCOPROTEINS; PROPIONATES; QUINOLINES; TEMPERATURE; TETRAZOLIUM SALTS; THIAZOLES; TRICHOTHECENES;

ANIMALIA;

EID: 34248172465     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.03.012     Document Type: Article

References (45)

1. Allen J.D., van Loevezijn A., Lakhai J.M., van der Valk M., van Telligen O., Reid G., Schellens J.H.M., Koomen G.J., and Schinkel A.H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1 (2002) 417-425
2. Anderle P., Nieder E., Rubas W., Hilgendorf C., Spahn-Langguth H., Wunderli-Allenspach H., Merkle H.P., and Langguth P. P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J. Pharm. Sci. 87 (1998) 757-762
3. Artursson P., and Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991) 880-885
4. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46 (2001) 27-43
5. Berger V., Gabriel A.F., Sergent T., Trouet A., Larondelle Y., and Schneider Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol. Lett. 140-141 (2003) 465-476
6. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
7. 1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein. Toxicon 45 (2005) 285-291
8. Delie F., and Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limits of the Caco-2 model. Crit. Rev. Ther. Drug. 14 (1997) 221-286
9. Edwards S.G. Influence of agricultural practices on Fusarium infection of cereals and subsequent contamination of grain by trichothecenes mycotoxins. Toxicol. Lett. 153 (2004) 29-35
10. Ehrlich K.C., and Daigle K.W. Protein synthesis inhibition by 8-oxo-12,13-epoxytrichothecenes. Biochim. Biophys. Acta 923 (1987) 206-213
11. Eriksen G.S., and Alexander J. Nordic Council of Ministers. Fusarium Toxins in Cereals: A Risk Assessment (1998), TemaNord, Copenhagen pp. 7-44
12. Evers R., Kool M., van Deemter E., Janssen H., Calafat J., Oomen L.C.J.M., Paulusma C.C., Oude Elferink R.P.J., Baas F., Schinkel A.H., and Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101 (1998) 1310-1319
13. Garaleviciene D., Petersson H., and Elwinger K. Effects on health and blood plasma parameters of laying hens pure nivalenol in the diet. J. Anim. Physiol. Anim. Nutr. 86 (2002) 389-398
14. Gareis, M., Zimmermann, C., Schothorst, R., Paulsh, W., Vidnes, A., Bergsten, C., Paulsen, B., Brera, C., Miraglia, M., Grossi, S., Debegnach, F., 2003. Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU Member States. Final report of experts participating in Task 3.2.10, April 2003. Available at: http://europa.eu.int/comm/food/fs/scoop/task3210.pdf.
15. 4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208 (1995) 345-352
16. Gerk P.M., and Vore M. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J. Pharmacol. Exp. Ther. 302 (2002) 407-415
17. Gutmann H., Fricker G., Torok M., Michael S., Beglinger C., and Drewe J. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm. Res. 16 3 (1999) 402-407
18. Hedman R., Pettersson, and Lindberg J.E. Absorption and metabolism of nivalenol in pigs. Arch. Tierernahr. 50 (1997) 13-24
19. Hidalgo I.J., and Borchardt R.T. Transport of bile acids in a human intestinal epithelial cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (1990) 736-749
20. Hsia C.C., Wu Z.Y., Li Y.S., Zhang F., and Sun Z.T. Nivalenol, a main Fusarium toxin in dietary foods from high-risk areas of cancer of esophagus and gastric cardia in China, induced benign and malignant tumors in mice. Oncol. Rep. 12 (2004) 449-456
21. Ihaka R., and Gentleman R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5 (1996) 299-314
22. Jy Y., and Morris M.E. Transport of dietary phenetyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein. Biochem. Pharmacol. 70 (2005) 640-647
23. Krishna R., and Mayer L.D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 11 (2000) 265-283
24. Leblanc J.C., Tard A., Volatier J.L., and Verger P. Estimated dietary exposure to principal food mycotoxines from the first French Total Diet Study. Food Addit. Contam. 22 (2005) 652-672
25. Lee C.H. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Curr. Med. Chem. -Anti-Cancer Agents 4 (2004) 43-52
26. Macdonald H.R., and Koch C.J. Energy metabolism and T-cell-mediated cytolysis. J. Exp. Med. 146 (1977) 698-709
27. Makhey V.D., Guo A., Norris D.A., Hu P., Yan J., and Sinko P.J. Characterization of the regional kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm. Res. 15 (1998) 1160-1167
28. Onji Y., Dohi Y., Aoki Y., Moriyama T., Nagami H., Uno M., Tanaka T., and Yamazoe Y. Deepoxynivalenol: a new metabolite of nivalenol found in the excreta of orally administered rats. J. Agric. Food. Chem. 37 (1989) 478-481
29. Pinto M., Robine-Leon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., and Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. 47 (1983) 323-330
30. Placinta C.M., D'Mello J.P.F., and Macdonald A.M.C. A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins. Anim. Feed Sci. Technol. 78 (1999) 21-37
31. Poapolathep A., Sugita-Konishi Y., Doi K., and Kumagai S. The fates of trichothecene mycotoxins, nivalenol and fusarenon-X, in mice. Toxicon 41 (2003) 1047-1054
32. Rotter B., Prelusky D.B., and Petska J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 48 (1996) 1-34
33. Ruiz-Garcia A.R., Lin H., Pla-Delfina J.M., and Hu M. Kinetic characterization of secretory transport of a new ciprofloxacin derivative (CN97100) across Caco-2 cell monolayers. J. Pharm. Sci. 91 (2002) 2511-2519
34. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A.A.M., and Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96 (1995) 1698-1705
35. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55 (2003) 3-29
36. Schollenberger M., Müller H.-M., Rüfle M., Suchy S., Plank S., and Drochner W. Natural occurrence of 16 Fusarium toxins in grains and feedstuffs of plant origin from Germany. Mycopathologia 161 (2006) 43-52
37. Schrickx J., Lektarau K., and Fink-Gremmels J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch. Toxicol. 80 (2006) 243-249
38. Smith A.J., van Helvoort A., van Meer G., Szabo K., Welker E., Szakacs G., Varadi A., Sarkadi B., and Borst P. MDR3 p-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J. Biol. Chem. 275 (2000) 23530-23539
39. Sugiura Y., Fukasaku K., Tanaka T., Matsui Y., and Ueno Y. Fusarium poae and Fusarium crookwellense, Fungi responsible for the natural occurrence of nivalenol in Hokkaido. Appl. Environ. Microbiol. 59 (1993) 3334-3338
40. Sundstol-Eriksen G., and Pettersson H. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit. Contam. 20 6 (2003) 579-582
41. Takano M., Yumoto R., and Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 109 (2006) 137-161
42. Tanaka T., Hasegawa A., Matsuki Y., and Ueno Y. A survey of natural occurrence of nivalenol, deoxynivalenol and zearalenone in food stuffs and health foods in Japan. Food Addit. Contam. 2 (1985) 259-265
43. Ueno Y. Effect of trichothecene mycotoxins on farm animals. In: Ueno Y. (Ed). Trichothecenes. Chemical, Biological and Toxicological Aspects (1983), Elsevier, Amsterdam 135-146
44. Xia C.Q., Liu N., Yang D., Miwa G., and Gan L.-S. Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab. Dispos. 33 (2005) 637-643
45. Zhang Y., Bachmeier C., and Miller D.W. In vitro and in vivo models for assessing drug efflux transporter activity. Adv. Drug Deliv. Rev. 55 (2003) 31-51